EICHORCondition: Advanced Solid Tumors · Sponsor: Shanghai Pushi Medical Science Co. Ltd
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
this is a single-arm, open phase I clinical trial evaluating the safety, tolerability, pharmacokinetics, pharmacokinetics, and preliminary efficacy of FS-8002 and combination therapy in patients with advanced solid tumors
This description comes directly from the study's public registry record.
Xiaojun Wang, Master · 021-50796193 · xiaojun_wang@junshipharma.com
Always discuss trial participation with your own doctor first.
| Beijing Cancer Hospital | Beijing, Beijing Municipality, China | Recruiting |
| Fujian Cancer hospital | Fujian, Fuzhou, China | Recruiting |
| The First Affiliated Hospital of Zhejiang Medical University | Zhejiang, Hangzhou, China | Recruiting |
| Harbin Medical University Cancer Hospital | Heilongjiang, Harbin, China | Recruiting |
| Cancer Hospital of Shandong First Medical University(Shandong Cancer Institute,Shandong Cancer Hospital) | Shandong, Jinan, China | Recruiting |
| Meizhou People's Hospital | Guangdong, Meizhou, China | Recruiting |
| The First Affiliated Hospital of China Medical University | Shenyang, Shenyang, China | Recruiting |
| Hebei General Hospital | Hebei, Shijiazhuang, China | Recruiting |
| Union Hospital, Tongji Medical College | Hubei, Wuhan, China | Recruiting |
| Hubei Cancer Hospital | Hubei, Wuhan, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06832982